Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus

Brain Research

Volumn 956, Issue 1, 2002, Pages 126-135

  Ashe, Paula C ^a   Chlan Fourney, Jennifer ^a   Juorio, Augusto V ^a   Li, Xin Min ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

In situ hybridization; Prefrontal cortex; Schizophrenia; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; IBOTENIC ACID; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; CELL VIABILITY; CONTROLLED STUDY; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MOLECULE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; ANIMALS, NEWBORN; BRAIN INJURIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IBOTENIC ACID; IN SITU HYBRIDIZATION; MALE; PREFRONTAL CORTEX; RATS; RNA, MESSENGER; SCHIZOPHRENIA; STRESS;

EID: 0037159638     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03176-1     Document Type: Article

References (42)

1. 3H]MK-801 binding is not altered in prefrontal cortex or nucleus accumbens of rats with neonatal hippocampal damage. Soc. Neurosci. Abstr. 22:1996;1674.
2. Alderson R.F., Alterman A.L., Barde A.Y., Lindsay R.M. Brain-derived neurotrophic factor increases survival and differentiated function of rat septal cholinergic neurons in culture. Neuron. 5:1990;297-306.
3. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 389:1997;856-860.
4. Barde Y.A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1:1982;549-553.
5. Brouha A.K., Shannon Weickert C., Hyde T.M., Herman M.M., Murray A.M., Bigelow L.B., Weinberger D.R., Kleinman J.E. Reductions in brain-derived neurotrophic factor mRNA in the hippocampus of patients with schizophrenia. Soc. Neurosci. Abstr. 22:1996;1680.
6. Croll S.D., Weigand S.J., Anderson K.D., Lindsay R.M., Nawa H. Regulation of neuropeptides in adult forebrain by the neurotrophins BDNF and NGF. Eur. J. Neurosci. 6:1994;1343-1353.
7. Cunningham M.G., McKay R.D.G. A hypothermic miniaturized stereotaxic instrument for surgery in newborn rats. J. Neurosci. Methods. 47:1993;105-114.
8. DeLisi L.E. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging. Schizophr. Res. 23:1997;119-129.
9. Eastwood S.L., Burnet W.J., Harrison P.J. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience. 66:1995;309-319.
10. Fonnum F. Topographical and subcellular localization of choline acetyltransferase in the rat hippocampal region. J. Neurochem. 17:1970;1029-1037.
11. Germroth P., Schwerdtfeger W.K., Buhl E.H. GABAergic neurons in the entorhinal cortex project to the hippocampus. Brain Res. 494:1989;187-192.
12. Ghosh A., Carnahan J., Greenberg M.E. Requirement for BDNF in activity-dependent survival of cortical neurons. Science. 263:1994;1618-1623.
13. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry. 54:1997;943-952.
14. Jones K.R., Farinas I., Backus C., Reichardt L.F. Targetted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell. 76:1994;989-999.
15. Kang H., Schuman E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science. 267:1995;1658-1662.
16. Koh J.-Y., Gwag B.J., Lobner D., Choi D.W. Potentiated necrosis of cultured cortical neurons by neurotrophins. Science. 268:1995;573-575.
17. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA. 92:1995;8865-8870.
18. Lebmann V., Gottmann K., Heumann R. BDNF and NT-4/5 enhance glutamatergic synaptic transmission in cultured hippocampal neurons. NeuroReport. 6:1994;21-25.
19. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., Barde Y.A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 341:1989;149-152.
20. Levine E., Dreyfus C., Black I., Plummer M. Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via post synaptic tyrosine kinase receptors. Proc. Natl. Acad. Sci. USA. 92:1995;8074-8077.
21. Lillrank S.M., Lipska B.K., Bachus S.E., Wood G.K., Weinberger D.R. Amphetamine-induced c-fos mRNA expression is altered in rats with neonatal ventral hippocampal damage. Synapse. 23:1996;292-301.
22. Lindefors N., Brodin E., Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience. 65:1995;661-670.
23. Lindvall O., Ernfors P., Bengzon J., Kokaia Z., Smith M.-L., Siesjo B.K., Persson H. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc. Natl. Acad. Sci. USA. 89:1992;648-652.
24. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 9:1993;67-75.
25. Maisonpierre P.C., Le Beau M.M., Espinosa R., Ip N.Y., Belluscio L., De La Monte S.M., Squinto S., Furth M.E., Yancopoulos G.D. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal locations. Genomics. 10:1991;558-568.
26. McCallister A.K., Lo D.C., Katz L.C. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron. 15:1995;791-803.
27. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 60:1993;1650-1657.
28. Molteni R., Lipska B.K., Figini A., Khaing Z.Z., Weinberger D.R., Racagni G., Riva M.A. Developmental and stress-induced changes of neurotrophic factor expression in an animal model of schizophrenia. Soc. Neurosci. Abstr. 25:1999;513.
29. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15:1995;7539-7547.
30. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Edition:1986;Academic Press, San Diego, USA.
31. Sajatovic M., Meltzer H.Y. The effect of short-term electroconvulsive treatment plus neuroleptics in treatment-resistant schizophrenia and schizoaffective disorders. Conv. Ther. 9:1993;167-175.
32. Schroeder H., Grecksch G., Becker A., Bogerts B., Hoellt V. Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion. Psychopharmacology. 145:1999;61-66.
33. Singh M., Meyer E.M., Simpkins J.W. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology. 136:1995;2320-2324.
34. Smith M.A., Makino S., Kim S.Y., Kvetnansky R., Post R.M. Stress increases brain-derived neurotrophic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology. 136:1995;3743-3750.
35. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15:1995;1768-1777.
36. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-598.
37. Toyooka K., Shirakawa O., Kitamura N., Hashimoto T., Maeda K., Wakabayashi K., Takahashi H., Someya T., Nawa H. Large individual variation in BDNF content in human brain and serum. Soc. Neurosci. Abstr. 25:1999;515.
38. 2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17:1997;2785-2795.
39. Vicente A.M., Macciardi F.M., Verga M., Nizik H.B., King N., Bean G., Kennedy J.L. Association between the BDNF gene and schizophrenia. Soc. Neurosci. Abstr. 22:1996;241.
40. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669.
41. Zafra F., Castern E., Thoenen H., Lindholm D. Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in the hippocampal neurons. Proc. Natl. Acad. Sci. USA. 88:1991;10037-10041.
42. Zafra F., Hengerer B., Leibrock J., Thoenen H., Lindholm D. Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J. 9:1990;3545-3550.